Header cover image

U.S. Clinical Research and Equipment Industry Analysis

UpdatedMar 27, 2024
DataAggregated Company Financials
Companies62
  • 7D-1.9%
  • 3M5.0%
  • 1Y3.9%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.0%, driven by Thermo Fisher Scientific declining 2.4%. On the other hand Stevanato Group is actually up 9.0%. Over the past 12 months, the industry was up 3.4%. Looking forward, earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the U.S. Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 27 Mar 2024US$735.1bUS$142.1bUS$12.8b43.8x57.4x5.2x
Fri, 23 Feb 2024US$720.2bUS$142.3bUS$12.5b42.5x57.4x5.1x
Sun, 21 Jan 2024US$687.1bUS$153.8bUS$14.2b35.9x48.5x4.5x
Tue, 19 Dec 2023US$684.6bUS$153.7bUS$14.2b37x48.1x4.5x
Thu, 16 Nov 2023US$603.3bUS$153.9bUS$13.9b33.7x43.4x3.9x
Sat, 14 Oct 2023US$629.3bUS$154.6bUS$11.2b33.2x56.2x4.1x
Mon, 11 Sep 2023US$687.1bUS$154.6bUS$11.2b31.6x61.3x4.4x
Wed, 09 Aug 2023US$733.4bUS$154.6bUS$11.2b30.3x65.5x4.7x
Fri, 07 Jul 2023US$687.8bUS$152.4bUS$12.5b29.6x55x4.5x
Sun, 04 Jun 2023US$683.1bUS$152.4bUS$12.5b29.1x54.6x4.5x
Tue, 02 May 2023US$701.9bUS$152.9bUS$9.4b29.5x74.4x4.6x
Thu, 30 Mar 2023US$708.3bUS$154.5bUS$10.8b26.3x65.5x4.6x
Sat, 25 Feb 2023US$712.1bUS$154.3bUS$11.0b30.1x65x4.6x
Mon, 23 Jan 2023US$769.6bUS$155.3bUS$8.5b30.9x90.3x5x
Wed, 21 Dec 2022US$731.5bUS$155.2bUS$8.8b28x83.3x4.7x
Fri, 18 Nov 2022US$745.1bUS$154.9bUS$8.8b27.5x84.2x4.8x
Sun, 16 Oct 2022US$693.0bUS$152.5bUS$17.0b23.6x40.7x4.5x
Tue, 13 Sep 2022US$811.0bUS$152.3bUS$17.3b30.9x46.8x5.3x
Thu, 11 Aug 2022US$836.4bUS$151.9bUS$18.0b33.6x46.5x5.5x
Sat, 09 Jul 2022US$747.6bUS$148.1bUS$20.1b31.1x37.2x5x
Mon, 06 Jun 2022US$756.1bUS$148.1bUS$20.1b31.2x37.6x5.1x
Wed, 04 May 2022US$778.7bUS$151.0bUS$21.1b32.5x36.9x5.2x
Fri, 01 Apr 2022US$882.4bUS$146.0bUS$25.4b36.3x34.8x6x
Sun, 27 Feb 2022US$854.0bUS$146.1bUS$25.3b38.5x33.8x5.8x
Tue, 25 Jan 2022US$836.8bUS$138.0bUS$27.3b40x30.6x6.1x
Thu, 23 Dec 2021US$979.0bUS$138.0bUS$27.3b44.2x35.8x7.1x
Sat, 20 Nov 2021US$972.7bUS$137.8bUS$27.1b47.1x35.9x7.1x
Mon, 18 Oct 2021US$718.1bUS$106.0bUS$18.5b46.4x38.7x6.8x
Wed, 15 Sep 2021US$736.8bUS$106.0bUS$18.6b49.9x39.6x7x
Fri, 13 Aug 2021US$714.8bUS$105.8bUS$18.7b49.3x38.3x6.8x
Tue, 08 Jun 2021US$601.2bUS$97.3bUS$17.5b41.5x34.4x6.2x
Price to Earnings Ratio

37x


Total Market Cap: US$569.5bTotal Earnings: US$15.4bTotal Revenue: US$92.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Clinical Research and Equipment Industry Price to Earnings3Y Average 49.4x202220232024
Current Industry PE
  • Investors are optimistic on the American Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 58.4x which is higher than its 3-year average PE of 49.4x.
  • The industry is trading close to its 3-year average PS ratio of 5.3x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have declined 5.9% per year over the last three years.
  • Meanwhile revenues for these companies have grown 15% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Clinical Research and Equipment compare with similar industries?

US Market0.56%
Healthcare-0.40%
Life Sciences-1.90%
Clinical Research and Equipment-1.90%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
STVN Stevanato GroupUS$31.799.0%
+US$897.4m
29.6%PE54.8x
MEDP Medpace HoldingsUS$402.753.3%
+US$392.2m
121.9%PE43.8x
MTD Mettler-Toledo InternationalUS$1.32k1.0%
+US$265.6m
-10.8%PE35.7x
BIO Bio-Rad LaboratoriesUS$340.521.2%
+US$115.2m
-27.7%PS3.6x
ILMN IlluminaUS$133.800.5%
+US$101.7m
-37.4%PS4.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ILMN

US$133.80

Illumina

7D

0.5%

1Y

-37.4%

STVN

US$31.79

Stevanato Group

7D

9.0%

1Y

29.6%

A

US$144.41

Agilent Technologies

7D

-2.0%

1Y

8.9%

BIO

US$340.52

Bio-Rad Laboratories

7D

1.2%

1Y

-27.7%

RGEN

US$183.84

Repligen

7D

-7.5%

1Y

9.7%

CDXC

US$3.84

ChromaDex

7D

41.7%

1Y

147.7%

WST

US$388.22

West Pharmaceutical Services

7D

-1.9%

1Y

14.2%

TMO

US$568.82

Thermo Fisher Scientific

7D

-2.4%

1Y

2.6%

BRKR

US$92.40

Bruker

7D

0.4%

1Y

21.2%